Individual breathlessness trajectories do not match summary trajectories in advanced cancer and chronic obstructive pulmonary disease: Results from a longitudinal study

Palliative Medicine

Volumn 24, Issue 8, 2010, Pages 777-786

  Bausewein, Claudia ^a   Booth, Sara ^b   Gysels, Marjolein ^a,c   Kühnbach, Robert ^d   Haberland, Birgit ^d   Higginson, Irene J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cancer; chronic obstructive pulmonary disease; dyspnoea; palliative care; trajectories

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; DISEASE SEVERITY; DYSPNEA; FATIGUE; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OUTCOME ASSESSMENT; OUTPATIENT CARE; POPULATION RESEARCH; QUESTIONNAIRE; TERMINAL CARE;

AGED; DISEASE PROGRESSION; DYSPNEA; EPIDEMIOLOGIC METHODS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAL CAPACITY;

EID: 78149359065     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216310378785     Document Type: Article

References (37)

1. Solano JP, Gomes B. and Higginson IJ A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manag 2006 ; 31: 58-69.
2. Vigano A., Dorgan M., Buckingham J., Bruera E. and Suarez-Almazor ME Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 2000 ; 14: 363-374.
3. Hansen-Flaschen J. Chronic obstructive pulmonary disease: the last year of life. Respir Care 2004 ; 49: 90-97.
4. Murray SA and Sheikh A. Serial interviews for patients with progressive diseases. Lancet 2006 ; 368: 901-902.
5. National Institutes of Health. National Institutes of Health state-of-the-science conference statement on improving end-of-life care. 2004.
6. Lunney JR, Lynn J., Foley DJ, Lipson S. and Guralnik JM Patterns of functional decline at the end of life. J Am Med Assoc 2003 ; 289: 2387-2392.
7. Teno JM, Weitzen S., Fennell ML and Mor V. Dying trajectory in the last year of life: does cancer trajectory fit other diseases? [see comment]. J Palliat Med 2001 ; 4: 457-464.
8. Murray SA, Kendall M., Boyd K. and Sheikh A. Illness trajectories and palliative care. Br Med J 2005 ; 330: 1007-1011.
9. Gott M., Barnes S., Parker C., Payne S., Seamark D., Gariballa S., et al. Dying trajectories in heart failure. Palliat Med 2007 ; 21: 95-99.
10. Cooley ME, Short TH and Moriarty HJ Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Psychooncology 2003 ; 12: 694-708.
11. Burdon JGW, Juniper EF, Killian KJ, Hargreave FE and Campbell EJM. The perception of breathlessness in asthma. Am Rev Respir Dis 1982 ; 126: 825-828.
12. Mador MJ, Rodis A. and Magalang UJ Reproducibility of Borg scale measurements of dyspnea during exercise in patients with COPD. Chest 1995 ; 107: 1590-1597.
13. Kendrick KR, Baxi SC and Smith RM Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs 2000 ; 26: 216-222.
14. Booth S., Kelly MJ, Cox NP, Adams L. and Guz A. Does oxygen help dyspnea in patients with cancer? Am J Respir Crit Care Med 1996 ; 153: 1515-1518.
15. Wilson RC and Jones PW Long-term reproducibility of Borg scale estimates of breathlessness during exercise. Clin Sci 1991 ; 80: 309-312.
16. Mancini I. and Body JJ Assessment of dyspnea in advanced cancer patients. [see comment]. [Review] [15 refs]. Support Care Canc 1999 ; 7: 229-232.
17. Chang VT, Hwang SS, Feuerman M., Kasimis BS and Thaler HT The memorial symptom assessment scale short form (MSAS-SF). Cancer 2000 ; 89: 1162-1171.
18. Blinderman CD, Homel P., Billings JA, Tennstedt S. and Portenoy RK Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manag 2009 ; 38: 115-123.
19. Hearn J. and Higginson IJ Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Qual Health Care 1999 ; 8: 219-227.
20. Zigmond AS and Snaith RP The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 ; 67: 361-370.
21. Singer JD and Willett JB A framework for investigating change over time. In: Singer JD and Willett JB (eds) Applied longitudinal data analysis. Oxford: Oxford University Press, 2003, pp. 3-15.
22. Brown CG, McGuire DB, Beck SL, Peterson DE and Mooney KH Visual graphical analysis: a technique to investigate symptom trajectories over time. Nurs Res 2007 ; 56: 195-201.
23. Ries AL Minimally clinically important difference for the UCSD Shortness of breath questionnaire, Borg Scale, and visual analog scale. COPD 2004 ; 2: 105-110.
24. Altman DG Practical statistics for medical research 1991 ; Chapman & Hall, London.
25. Chiu TY, Hu WY, Lue BH, Yao CA, Chen CY and Wakai S. Dyspnea and its correlates in taiwanese patients with terminal cancer. J Pain Symptom Manag 2004 ; 28: 123-132.
26. Higginson IJ, Wade AM and McCarthy M. Effectiveness of two palliative support teams. J Public Health Med 1992 ; 14: 50-56.
27. Steinhauser KE, Clipp EC, Hays JC, Olsen M., Arnold R., Christakis NA, et al. Identifying, recruiting, and retaining seriously-ill patients and their caregivers in longitudinal research. Palliat Med 2006 ; 20: 745-754.
28. Eakin EG, Kaplan RM and Ries AL Measurement of dyspnoea in chronic obstructive pulmonary disease. Qual Life Res 1993 ; 2: 181-191.
29. Oga T., Nishimura K., Tsukino M., Sato S., Hajiro T. and Mishima M. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med 2007 ; 101: 146-153.
30. Lareau SC, Meek PM, Press D., Anholm JD and Roos PJ Dyspnea in patients with chronic obstructive pulmonary disease: does dyspnea worsen longitudinally in the presence of declining lung function? Heart Lung 1999 ; 28: 65-73.
31. Reuben DB and Mor V. Dyspnea in terminally ill cancer patients. Chest 1986 ; 89: 234-236.
32. Elmqvist MA, Jordhoy MS, Bjordal K., Kaasa S. and Jannert M. Health-related quality of life during the last three months of life in patients with advanced cancer. Support Care Canc 2009 ; 17: 191-198.
33. Henoch I., Bergman B., Gustafsson M., Gaston-Johansson F. and Danielson E. The impact of symptoms, coping capacity, and social support on quality of life experience over time in patients with lung cancer. J Pain Symptom Manag 2007 ; 34: 370-379.
34. Stromgren AS, Sjogren P., Goldschmidt D., Petersen MA, Pedersen L., Hoermann L., et al. A longitudinal study of palliative care: patient-evaluated outcome and impact of attrition. Cancer 2005 ; 103: 1747-1755.
35. Cheung WY, Barmala N., Zarinehbaf S., Rodin G., Le LW and Zimmermann C. The association of physical and psychological symptom burden with time to death among palliative cancer outpatients. J Pain Symptom Manag 2009 ; 37: 297-304.
36. Tishelman C., Petersson LM, Degner LF and Sprangers MA Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death. J Clin Oncol 2007 ; 25: 5381-5389.
37. Langsetmo L., Platt RW, Ernst P. and Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med 2008 ; 177: 396-401.